What both stacks have in common Both stacks combine a GHRH analog with ipamorelin, a synthetic pentapeptide that acts on the ghrelin receptor to trigger a short growth-hormone pulse without meaningfully raising cortisol, ACTH, prolactin, or other pituitary hormones
Melanie Jay, MD, MS, is a professor of medicine and population health at NYU Langone Health and a physician investigator specializing in obesity
GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)
Youre at the highest risk for getting Hashimotos disease if youre a middle-aged woman experiencing other autoimmune disorders and have a family history of Hashimotos
Additionally, the injections may not be given in case of uncontrolled diabetes mellitus, certain heart conditions, and pregnancy
Pancreatitis has been reported with GLP-1 receptor agonists